- Home
- / Berry Genomics
Berry Genomics
Stock Price
¥13.7
2023-03-28
Market Capitalization
¥4.9 B
2023-03-28
Revenue
¥1.4 B
FY, 2021
Berry Genomics Summary
Company summary
- Overview
- Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications. The company focuses on genetic testing and oncology testing.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- CN | view all locations
- Cybersecurity rating
- ESG rating
Berry Genomics Financials
Summary financials
- Revenue (Q3, 2022)
- ¥384.3M
- Gross profit (Q3, 2022)
- ¥165.6M
- Net income (Q3, 2022)
- ¥3.3M
- Cash (Q3, 2022)
- ¥224.6M
- EBIT (Q3, 2022)
- ¥24.8M
- Enterprise value
- $5.0B
News
Footer menu
Products
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension